Article citationsMore>>

Duvignaud, A., Jaspard, M., Etafo, I.C., Gabillard, D., Serra, B., Abejegah, C., le Gal, C., Abidoye, A.T., et al. (2021) Lassa Fever Outcomes and Prognostic Factors in Nigeria (LASCOPE): A Prospective Cohort Study. The Lancet Global Health, 9, E469-E478.
https://doi.org/10.1016/S2214-109X(20)30518-0

has been cited by the following article:

• TITLE: Lassa Fever: Patients Profile and Treatment Outcomes at Benue State University Teaching Hospital Makurdi, North-Central Nigeria

  AUTHORS: Tsavyange Peter Mbaave, Onyilo Ogbu, Patrick O. Echekwube, Terrumun Zaiyol Swende, Igba Terhile Igbah

  KEYWORDS: Lassa Fever, Treatment Outcome, Benue State, Nigeria

  JOURNAL NAME: Advances in Infectious Diseases, Vol.13 No.4, December 29, 2023

  ABSTRACT: Lassa fever is a viral haemorrhagic fever found mostly in West Africa where it is endemic but generates periodic outbreaks in the dry seasons. The virus is spread by the rat species named mastomys natalensis. While the illness is minor in most cases, the mortality is significant in hospitalized patients. Few completely equipped treatment centers existed in Nigeria previous to current increase in frequency requiring demand for new treatment centers without the full complement of essential capabilities. Aim: To analyze the profile and treatment outcome in patients hospitalized in one of such new resource-constrained centers at the Benue State University Teaching Hospital Makurdi, Nigeria. Methodology: This was a retrospective, descriptive hospital-based research encompassing January 2020 to March 2023. Medical records of those admitted to the isolation center were reviewed. The relevant data was coded and analyzed using IBM SPSS version 23. Results: One hundred and ten (110) individuals were hospitalized for probable or suspected Lassa fever throughout the research period. A total of 35 confirmed patients satisfied the inclusion criteria and were included as the study subjects. There were 23 (65.7%) men and 12 (34.3%) females. Their mean age was 35.36 ± 12.21 years (range 15-61 years). The treatment outcome showed that 24 (75%) survived and were discharged, 5 (15.6%) were referred out of the facility for dialysis and 3 died, providing a mortality of 8.6%. The causes of mortality in study patients were acute kidney injury and encephalopathy. Conclusion: Lassa fever is endemic in Benue state with all types of individuals afflicted. The outcome of treatment was good despite resource difficulties. Lassa fever can be successfully managed even in resource-challenged situations typically encountered in developing countries.